Research into leukemia drug makes National Cancer Institute doctor a Sammies finalist

Published: July 15, 2020, 11:14 a.m.

b"A breakthrough leukemia drug is on the market through a major drug manufacturer. But a research doctor, at the National Cancer Institute at the National Institutes of Health, made the discoveries that led to the drug in the first place. Now he's expanding work on what are known as recombinant immunotoxins. For his work he's a finalist in this year's Service to America Medals program. Ira Pastan spoke more to Federal Drive with Tom Temin.\\nLearn more about your ad choices. Visit megaphone.fm/adchoices"